254 related articles for article (PubMed ID: 17190795)
21. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3.
Cui Y; Liao YC; Lo SH
Mol Cancer Res; 2004 Apr; 2(4):225-32. PubMed ID: 15140944
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of C-terminal tensin-like molecule promotes the tumorigenicity of colon cancer through beta-catenin.
Liao YC; Chen NT; Shih YP; Dong Y; Lo SH
Cancer Res; 2009 Jun; 69(11):4563-6. PubMed ID: 19487278
[TBL] [Abstract][Full Text] [Related]
24. SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.
Machiyama H; Yamaguchi T; Sawada Y; Watanabe TM; Fujita H
FEBS J; 2015 Oct; 282(20):4034-55. PubMed ID: 26258764
[TBL] [Abstract][Full Text] [Related]
25. Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion.
Hall EH; Daugherty AE; Choi CK; Horwitz AF; Brautigan DL
J Biol Chem; 2009 Dec; 284(50):34713-22. PubMed ID: 19826001
[TBL] [Abstract][Full Text] [Related]
26. C-terminal tensin-like gene functions as an oncogene and promotes cell motility in pancreatic cancer.
Al-Ghamdi S; Cachat J; Albasri A; Ahmed M; Jackson D; Zaitoun A; Guppy N; Otto WR; Alison MR; Kindle KB; Ilyas M
Pancreas; 2013 Jan; 42(1):135-40. PubMed ID: 22750970
[TBL] [Abstract][Full Text] [Related]
27. 1H, 15N and 13C chemical shift assignments of the SH2 domain of human tensin2 (TENC1).
Chen L; Liu C; Rui F; Zhu G
Biomol NMR Assign; 2011 Oct; 5(2):211-4. PubMed ID: 21461930
[TBL] [Abstract][Full Text] [Related]
28. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
Lubman OY; Waksman G
J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
[TBL] [Abstract][Full Text] [Related]
29. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
Rogers JA; Cheng HY; Smithgall TE
Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
[TBL] [Abstract][Full Text] [Related]
30. Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma.
Chan LK; Chiu YT; Sze KM; Ng IO
Oncotarget; 2015 Aug; 6(25):20964-76. PubMed ID: 26035355
[TBL] [Abstract][Full Text] [Related]
31. Presence of an SH2 domain in the actin-binding protein tensin.
Davis S; Lu ML; Lo SH; Lin S; Butler JA; Druker BJ; Roberts TM; An Q; Chen LB
Science; 1991 May; 252(5006):712-5. PubMed ID: 1708917
[TBL] [Abstract][Full Text] [Related]
32. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
33. Tensin stabilizes integrin adhesive contacts in Drosophila.
Torgler CN; Narasimha M; Knox AL; Zervas CG; Vernon MC; Brown NH
Dev Cell; 2004 Mar; 6(3):357-69. PubMed ID: 15030759
[TBL] [Abstract][Full Text] [Related]
34. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
35. Cten mRNA expression is correlated with tumor progression in thymoma.
Sasaki H; Yukiue H; Kobayashi Y; Fukai I; Fujii Y
Tumour Biol; 2003; 24(5):271-4. PubMed ID: 15001839
[TBL] [Abstract][Full Text] [Related]
36. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
37. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
38. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
39. SH2 domain specificity and activity modified by a single residue.
Marengere LE; Songyang Z; Gish GD; Schaller MD; Parsons JT; Stern MJ; Cantley LC; Pawson T
Nature; 1994 Jun; 369(6480):502-5. PubMed ID: 7515480
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation of novel phosphotyrosine mimetic inhibitors targeting the Src homology 2 domain of signaling lymphocytic activation molecule (SLAM) associated protein.
Chu CY; Chang CP; Chou YT; Handoko ; Hu YL; Lo LC; Lin JJ
J Med Chem; 2013 Apr; 56(7):2841-9. PubMed ID: 23470190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
